Eight Trade Ideas and A Recap of our Latest
Most Popular - Vascepa’s commercial prospects are one of the hottest topics of debate in biotechnology, and this week PropThink outlined why you can trade Amarin (AMRN) in … Continue Reading
Read nowMost Popular - Vascepa’s commercial prospects are one of the hottest topics of debate in biotechnology, and this week PropThink outlined why you can trade Amarin (AMRN) in … Continue Reading
Read nowLong Ideas - ResMed (RMD) is suing a new and low-cost competitor in the Continues Positive Airway Pressure market. The target, 3B Medical, isn’t taking the litigation lying … Continue Reading
Read nowLong Ideas - A price target reduction from RBC Capital Markets took $1.06 (or 3.4%) out of Endo Health Solutions (ENDP) Thursday, noting risks to the company’s pain … Continue Reading
Read nowLong Ideas - The spin doctors have done a great job pressuring Keryx BioPharmaceuticals (KERX) recently, pulling out all the stops to drive the stock down. Massive share … Continue Reading
Read nowLong Ideas - Reuters reported on Wednesday afternoon that, according to industry sources, Endo Health Solutions (ENDP) is in talks with potential buyers of the business. Our “Trouble … Continue Reading
Read nowLong Ideas - Endo Health Solutions (NASDAQ:ENDP) re-established financial guidance Thursday night, re-affirming 2012’s prior outlook and, as expected, guiding expectations lower for revenue and EPS in 2013. This … Continue Reading
Read nowLong Ideas - Against a backdrop of growing opioid abuse in the U.S., Endo Health Solutions (NASDAQ:ENDP) announced another step Monday night in its efforts to curb abuse … Continue Reading
Read now